SIBO with Lactulose Breath Test

Overview

The SIBO with Lactulose Breath Test monitors hydrogen and methane levels in breath samples collected over time to explore fermentation activity along the small intestine. These gases arise when carbohydrates that are not fully digested interact with intestinal bacteria, releasing measurable gases that reflect microbial activity higher up in the digestive system than usual. Variations in hydrogen may be related to certain bacterial populations, while methane presence generally corresponds to methane-producing microorganisms, offering insight into microbial balance and digestive processes.

This test is particularly informative for individuals interested in understanding their digestive dynamics, especially when experiencing general issues such as bloating, discomfort, or irregular digestion. Since lactulose is not absorbed by the body, it travels through the entirety of the small intestine, enabling a comprehensive assessment of fermentation patterns. By tracking hydrogen and methane trends during the breath collection period, the test presents a profile of digestive fermentation that correlates with digestive wellbeing and nutrient handling.

The SIBO with Lactulose Breath Test offers a practical approach to examining gas concentrations over time, which can complement awareness of digestive comfort and overall gut health. Observing these trends alongside lifestyle factors and personal symptoms can support a deeper understanding of individual digestive responses and carbohydrate tolerance. This information may be used to guide lifestyle choices related to diet, gut function, and general wellbeing.

SIBO with Lactulose Breath Test is intended for informational, educational, wellness and/or research purposes only. It is not intended for use in medical diagnosis, disease screening or clinical decision-making. SIBO with Lactulose Breath Test is not a replacement for clinical laboratory testing and does not provide medical diagnoses. This content is intended for general information within the EU market and should not be interpreted as a regulated in-vitro diagnostic claim.